| Literature DB >> 20610674 |
Jennifer Rosen1, Susan Beekmann, Philip Polgreen, Matthew Moore.
Abstract
Infectious disease physicians were surveyed to determine whether the new penicillin breakpoint change will translate into increased penicillin use and to identify barriers to intravenous (i.v.) penicillin use for pneumococcal infections. The inconvenience of i.v. penicillin may limit its use despite a reduction in numbers of infections considered resistant.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20610674 PMCID： PMC2937691 DOI： 10.1128/JCM.01012-10
Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948